Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis

Leuk Lymphoma. 2023 Apr;64(4):889-892. doi: 10.1080/10428194.2023.2181656. Epub 2023 Feb 27.

Authors

Stefano Molica¹, Diana Giannarelli²

Affiliations

¹ Department of Haematology, Hull University Teaching Hospitals NHS Trust, Hull, UK.
² Biostatistics Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

PMID: 36847160
DOI: 10.1080/10428194.2023.2181656

No abstract available

Publication types

Meta-Analysis
Systematic Review
Letter

MeSH terms

Adenine
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Piperidines
Prognosis

Substances

ibrutinib
Adenine
Piperidines